Get started
JUBILANT PHARMOVA LIMITEDJUBILANT PHARMOVA LIMITEDJUBILANT PHARMOVA LIMITED

JUBILANT PHARMOVA LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

JUBLPHARMA chart


Full chart

JUBLPHARMA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪153.05 B‬ INR
Dividend yield (indicated)
0.52%
Price to earnings Ratio (TTM)
18.20
Basic EPS (TTM)
53.00 INR
Net income (FY)
‪8.39 B‬ INR
Revenue (FY)
‪72.34 B‬ INR
Shares float
‪65.50 M‬
Beta (1Y)
1.37

About JUBILANT PHARMOVA LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
jubilantpharmova.com
Headquarters
Noida
Founded
1978
ISIN
INE700A01033
FIGI
BBG000D1PZR8
Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. It operates through the following segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation, Generics, and Proprietary Novel Drugs. The Radiopharma segment is involved in products for diagnosis and treatment of various diseases, including Pulmonary Embolism, Cancer, Coronary Artery Diseaseand many others. The Allergy Immunotherapy segment provides diagnostic devices for skin testing. The CDMO Sterile Injectables segment offer manufacturing services including sterile fill and finish injectables, full-service ophthalmic offer, and ampoules. The Generics segment includes development, manufacturing, distribution, sales and marketing of generics formulations. The CRDMO segment relates to drug discovery and development services. The company was founded on June 21, 1978 and is headquartered in Noida, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

JUBLPHARMA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as JUBLPHARMA.

Frequently Asked Questions


The current price of JUBLPHARMA is 991.25 INR — it has increased by 2.93% in the past 24 hours. Watch JUBILANT PHARMOVA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange JUBILANT PHARMOVA LIMITED stocks are traded under the ticker JUBLPHARMA.
JUBLPHARMA stock has risen by 12.40% compared to the previous week, the month change is a 7.97% rise, over the last year JUBILANT PHARMOVA LIMITED has showed a 49.27% increase.
We've gathered analysts' opinions on JUBILANT PHARMOVA LIMITED future price: according to them, JUBLPHARMA price has a max estimate of 1,385.00 INR and a min estimate of 1,159.00 INR. Watch JUBLPHARMA chart and read a more detailed JUBILANT PHARMOVA LIMITED stock forecast: see what analysts think of JUBILANT PHARMOVA LIMITED and suggest that you do with its stocks.
JUBLPHARMA reached its all-time high on Nov 7, 2024 with the price of 1,309.00 INR, and its all-time low was 65.10 INR and was reached on Aug 28, 2013. View more price dynamics on JUBLPHARMA chart.
See other stocks reaching their highest and lowest prices.
JUBLPHARMA stock is 8.14% volatile and has beta coefficient of 1.37. Track JUBILANT PHARMOVA LIMITED stock price on the chart and check out the list of the most volatile stocks — is JUBILANT PHARMOVA LIMITED there?
Today JUBILANT PHARMOVA LIMITED has the market capitalization of ‪153.05 B‬, it has increased by 2.95% over the last week.
Yes, you can track JUBILANT PHARMOVA LIMITED financials in yearly and quarterly reports right on TradingView.
JUBILANT PHARMOVA LIMITED is going to release the next earnings report on Jul 18, 2025. Keep track of upcoming events with our Earnings Calendar.
JUBLPHARMA net income for the last quarter is ‪1.54 B‬ INR, while the quarter before that showed ‪1.01 B‬ INR of net income which accounts for 52.23% change. Track more JUBILANT PHARMOVA LIMITED financial stats to get the full picture.
Yes, JUBLPHARMA dividends are paid annually. The last dividend per share was 5.00 INR. As of today, Dividend Yield (TTM)% is 0.52%. Tracking JUBILANT PHARMOVA LIMITED dividends might help you take more informed decisions.
JUBILANT PHARMOVA LIMITED dividend yield was 0.56% in 2024, and payout ratio reached 9.44%. The year before the numbers were 0.88% and 102.79% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JUBILANT PHARMOVA LIMITED EBITDA is ‪10.54 B‬ INR, and current EBITDA margin is 14.57%. See more stats in JUBILANT PHARMOVA LIMITED financial statements.
Like other stocks, JUBLPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JUBILANT PHARMOVA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JUBILANT PHARMOVA LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JUBILANT PHARMOVA LIMITED stock shows the buy signal. See more of JUBILANT PHARMOVA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.